ERBB2 and neoplasm: Surprisingly, AI showed superior results in the precision for HER2 0 (0.93) and HER2 1+ scoring (0.93) detection [110], mainly due to a more clear separation of the HER2 ultra-low subgroup (score 0 with incomplete and faint staining in ≤10% of tumor cells) [100].